Delay in clozapine initiation and subsequent treatment response in schizophrenia spectrum disorders: a systematic review.
Clozapine remains the gold standard treatment for treatment-resistant schizophrenia (TRS), yet its initiation is frequently delayed for years, potentially contributing to irreversible clinical and functional deterioration. A previous systematic review suggested that longer delays in clozapine initiation are associated...